Skip to main content
 HHS.gov
 Search
 U.S. Department of Health & Human Services
  Search Close
 A-Z Index
 About HHS
Programs & Services
Grants & Contracts
Laws & Regulations
 Home > About > News > Trump Administration Adds Health Plans to June 2020 Plasma Donation Guidance
 Text Resize  
                                A
                                A
                                A
                            Print
                            Share
 Search News Releases
View 2016 - 1991 archive
 FOR IMMEDIATE RELEASEAugust 24, 2020Contact: HHS Press Office202-690-6343[email protected]Trump Administration Adds Health Plans to June 2020 Plasma Donation GuidanceToday, under the leadership of President Trump, the Office for Civil Rights (OCR) at the U.S Department of Health and Human Services (HHS) issued amended guidance on how the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule permits covered health care providers (e.g., hospitals, pharmacies, laboratories) and health plans to contact their patients and beneficiaries who have recovered from COVID-19 to inform them about how they can donate their plasma containing antibodies (known as "convalescent plasma") to help treat others with COVID-19.
OCR added health plans to the June 2020 guidance that explains how HIPAA permits covered health care providers and health plans to identify and contact patients and beneficiaries who have recovered from COVID-19 for individual and population-based case management or care coordination. The guidance also emphasizes that, without individuals' authorization, the providers and health plans cannot receive any payment from, or on behalf of, a plasma donation center in exchange for such communications with recovered individuals.
This announcement builds upon President Trump's call to action and existing partnership with commercial labs, insurers, providers, and pharmacies to send communications to individuals who have recovered from COVID-19 encouraging them to donate their convalescent plasma. This guidance to health care providers and health plans also complements the Food and Drug Administration's (FDA) recent issuance of an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in some hospitalized patients. The FDA has concluded this product may be effective in treating COVID-19.
"In response to the President's call for Americans who have recovered from COVID-19 to donate their plasma, OCR clarified how HIPAA permits health plans to contact their beneficiaries about plasma donation opportunities," said Roger Severino, OCR Director. "We will continue to use every tool at our disposal to beat this virus and keep Americans healthy," he added.
The amended guidance may be found at: https://www.hhs.gov/sites/default/files/guidance-on-hipaa-and-contacting-former-covid-19-patients-about-blood-and-plasma-donation.pdf.
For more information related to HIPAA and COVID-19, please visit: https://www.hhs.gov/hipaa/for-professionals/special-topics/hipaa-covid19/index.html.###Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.Last revised: August 24, 2020 Sign Up for News Release UpdatesEnter your email:
Email Subscribe to RSSReceive latest updates Related News ReleasesSecretary Azar Statement on Executive Order Supporting In-Person Schooling
  Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
  HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment Related Blog PostsConfronting Heightened Cybersecurity Threats Amid COVID-19
          Office of Population Affairs (OPA) Celebrating Title X: 1970-2020  
  Title X Family Planning Program Turns 50
          gen-perna-vaccine-blog-160x120  
  “We are ready to distribute vaccines all across America”
 Public Affairs Contacts
HHS Media InformationASPA Press ContactsHHS Agency Press Contacts
**View all**
 Connect With Us
 Sign Up for Email Updates To sign up for updates or to access your subscriber preferences, please enter your contact information below. Email
 HHS Headquarters U.S. Department of Health & Human Services
						200 Independence Avenue, S.W.
						Washington, D.C. 20201
						Toll Free Call Center: 1-877-696-6775​
 Contact HHS
                        Careers
                        HHS FAQs
                        Nondiscrimination Notice
 HHS Archive
                        Accessibility
                        Privacy Policy
                        Viewers & Players
 Budget/Performance
                        Guidance Portal 
                        Inspector General
                        EEO/No Fear Act
 FOIA
                        The White House
                        USA.gov


Back to *T*op